Search for Clinical Trial Results
Hyperplasia - 271 Studies Found
Status | Study |
Active, not recruiting |
Study Name: A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease Condition: Multicentric Castleman's Disease Date: 2009-11-30 Interventions:
|
Withdrawn |
Study Name: Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease Condition: Giant Lymph Node Hyperplasia Date: 2006-08-08 Interventions: Drug: Valganciclovir valganciclovir open label, two 450mg tablets orally, twice a day |
Recruiting |
Study Name: Tocilizumab for KSHV-Associated Multicentric Castleman Disease Condition:
|
Recruiting |
Study Name: TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial Condition: Multicentric Castleman Disease Date: 2017-01-31 Interventions: Drug: Thalidomide, cyclophosphamide and prednisone |
Terminated |
Study Name: Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy Condition:
Date: 2005-08-04 Interventions: Drug: Rituximab |
Recruiting |
Study Name: Unlock the Cell: Castleman's Disease Flow Cytometry Study Condition:
|
Recruiting |
Study Name: Castleman Disease Collaborative Network Biobank Condition:
|
Completed |
Study Name: A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease Condition:
|
Withdrawn |
Study Name: Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas Condition:
|